Cornea/External Disease News

NEW ORLEANS — Twice-daily Cequa improved symptoms of dry eye disease and decreased corneal staining in patients who were still symptomatic or exhibiting signs of disease on current therapy, according to a poster presented at Academy ’23.

The FDA has granted clearance to the expansion of Heidelberg Engineering’s Anterion platform, according to a press release.

NEW YORK — In this Healio Video Perspective from OSN New York, Susan Benton, president of Thea Pharma, discusses Iyuzeh for primary open-angle glaucoma. The treatment launched during the meeting.

NEW YORK — In this Healio Video Perspective from OSN New York, Blake Williamson, MD, explains how to combine a small aperture IOL and the Light Adjustable Lens in post-refractive ectatic corneas.

NEW YORK — In this Healio Video Perspective from OSN New York, Parag A. Majmudar, MD, discusses the need for ophthalmologists to embrace a paradigm shift toward treating patients with keratoconus in the early stages of disease.

LAS VEGAS — Oculus Inc. announced at Vision Expo West that it has partnered with Luvo for the U.S. launch of the Lucent for intense pulsed light therapy and the Darwin, which offers IPL with radiofrequency.

When I am performing tests to determine a patient’s glaucoma status — visual fields, retinal nerve fiber layer measurements on OCT, fundus photography, etc — I will also examine their ocular surface and do meibomian gland imaging.

The third annual Twin Cities Ocular Surface Disease Symposium will be hosted Oct. 21 and 22 in Minneapolis and will include 12 hours of CE credit for both optometrists and ophthalmologists.

LAS VEGAS — The foundation of dry eye care is based on “five pillars of wellness,” according to Laura M. Periman, MD.

We have all seen the chronic blepharitis patient that has attempted numerous unsuccessful treatment regimens and has visited numerous eye doctors looking for some relief. Interestingly, the cause of their chronic blepharitis might be secondary to Demodex infestation.